COVID-19 vaccine trials should seek worthwhile efficacy

被引：87

作者：

Krause, Philip ^{[1
]}

Fleming, Thomas R. ^{[2
]}

Longini, Ira ^{[3
]}

Henao-Restrepo, Ana Maria ^{[4
]}

Peto, Richard ^{[5
]}

机构：

[1] US FDA, Ctr Biol Evaluat & Res, Washington, DC 20204 USA

[2] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA 98195 USA

[3] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Coll Med, Gainesville, FL USA

[4] World Hlth Org, Hlth Emergencies Programme, CH-1211 Geneva 27, Switzerland

[5] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England

来源：

关键词：

D O I：

10.1016/S0140-6736(20)31821-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：741 / 743

页数：4

共 11 条

[1] Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks
Dean, Natalie E.
Gsell, Pierre-Stephane
Brookmeyer, Ron
Crawford, Forrest W.
Donnelly, Christl A.
Ellenberg, Susan S.
Fleming, Thomas R.
Halloran, M. Elizabeth
Horby, Peter
Jaki, Thomas
Krause, Philip R.
Longini, Ira M.
Mulangu, Sabue
Muyembe-Tamfum, Jean-Jacques
Nason, Martha C.
Smith, Peter G.
Wang, Rui
Henao-Restrepo, Ana M.
De Gruttola, Victor
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (14) : 1366 - 1369
[2] Current issues in non-inferiority trials
Flerning, Thomas R.
[J]. STATISTICS IN MEDICINE, 2008, 27 (03) : 317 - 332
[3] Rapid COVID-19 vaccine development
Graham, Barney S.
[J]. SCIENCE, 2020, 368 (6494) : 945 - 946
[4] Vaccine confidence in the time of COVID-19
Harrison, Emily A.
Wu, Julia W.
[J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2020, 35 (04) : 325 - 330
[5] COVID-19 vaccine design: the Janus face of immune enhancement
Hotez, Peter J.
Corry, David B.
Bottazzi, Maria Elena
[J]. NATURE REVIEWS IMMUNOLOGY, 2020, 20 (06) : 347 - 348
[6] US Food and Drug Administration, 2020, DEV LIC VACC PREV CO
[7] WHO, 2020, PUBL STAT COLL COVID
[8] WHO, 2021, INT RAND TRIAL CAND
[9] WHO, 2020, WHO TARG PROD PROF C, P1
[10] World Health Organization, 2020, COV 19 VACC ALL MUSL